Arbutus Biopharma | Investor Presentation Deck | 26 slides · page 15 of 26
The slide outlines two parallel study arms involving Imdusiran, VTP-300, NA, and Nivolumab.
Pitch deck · appendix_methodology · plan_implementation · dense density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 paragraph 2/2 title 1/1
Components 4
timeline paragraph paragraph headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1